Although more than 30,000 clinicians qualified to receive incentive payments in 2011, many physicians remain uncertain about the EHR Incentive Program and how to register for, report and attest to meaningful use, according to an article published May 14 in the Archives of Internal Medicine.

Physicians’ device and digital media adoption are evolving much faster than anticipated, especially when it comes to tablets, according to a May report from healthcare market research firm Manhattan Research.

LAS VEGAS—When treating a real-world sample of patients for intermittent claudication or critical limb ischemia, two off-label iliac artery stents showed a statistically significant performance goal for low major adverse event rates, according to the late breaking MOBILITY trial results presented May 10 at the 35th annual meeting of the Society for Cardiovascular Angiography and Interventions (SCAI). During the press conference, experts suggested that this study may further reinforce the role of percutaneous treatments over the more invasive surgical option for these sick patients.

Source: New England Journal of Medicine

BOSTON—Adding to the recent positive data from the FDA regarding Cameron Health’s subcutaneous implantable cardioverter-defibrillator (S-ICD) system, a study presented May 10 at the late-breaking clinical trial section at the 33rd annual scientific sessions of the Heart Rhythm Society found the device to be safe and effective.

The FDA has issued a draft guidance outlining its current thinking regarding information that should be included in premarket notifications for x-ray imaging devices with indications for use in pediatric populations.